Global Hypertrophic and Keloid Scar Treatment Market by Product (Topical, Injectable, Laser), by End Use (E-commerce, Clinics), by Scar Type (Keloid, Hypertrophic) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

Summary of the Report

Global hypertrophic and Keloid Scar Treatment Market was valued at USD4.8 billion in 2017. It is expected to grow 9.9% during the forecast period. This is due to a growing awareness about aesthetic appearance. This will likely lead to a rise in demand for procedures that enhance the esthetic appeal.

Scar treatment offers complete skin rejuvenation and enhances esthetic appeal. Women are the main consumers of esthetic products, and they have the highest demand. The market for hypertrophic and Keloid scar treatment has seen a rise in road accidents and burn victims.

According to the American Burn Association, more than 40,000 burn injury-related hospitalizations were recorded in 2016. This shows a rise in burn injuries worldwide. These injuries can cause hypertrophic scarring -- a common side effect. Surgery marks can also develop from road accidents that lead to surgery.

These factors and the subsequent rise in cosmetic procedures have fueled the demand for topical treatments. Laser therapies are faster and more effective than traditional treatments. They are also minimally invasive and can be used without pain, making them the most popular treatment option.

Scar Type Insights

The largest market share was held by the Keloid segment in 2017. It is expected to grow at the fastest rate over the forecast period. Keloid scars can be surgically removed, which is a better option than hypertrophic scars. They can be treated using topical treatments such as silicone gel sheets or laser therapies. Pressure therapy, and skin needling are all methods to reduce scarring.

Due to lower use of treatments to remove hypertrophic marks, the hypertrophic segment will likely experience sluggish growth in the future. Treatments include non-invasive techniques such as gels and creams or silicone sheets for minor injuries, and laser therapy in the case of severe injuries. In most cases, however, the treatment involves a combination of several therapies.

Product Insights

The market leader in terms of products was the topical segment in 2017. This is due to the increased demand for creams and silicone sheets as well as gels for the treatment of hypertrophic as well as keloid marks. These products are also easily accessible to consumers as Over the-the-Counter products (OTC), which is another reason for their high demand.

The fastest growing segment in the forecast is laser instruments. Laser treatments are painless and they will be the fastest growing. They also have many other benefits such as a shorter healing time and fewer adverse effects. Because they are quick and affordable, injectables dominated the market in 2017. Injectables have a longer-lasting effect than other treatments.

You can also find cryotherapy, compression therapy, radiotherapy and pressure therapy. Pressure garments speed up the healing process and decrease scarring. Cryotherapy is a treatment that uses cryoguns to treat scar tissue and reduce its size.

End-use Insights

Hospitals generated the highest revenue in 2017 based on end use. This is due to the wide variety of scar treatment options. Hospitals are preferable for emergency treatment, such as major accidents. They also provide care during recovery.

Because they offer specialized treatment, the clinics segment held a large market share in 2017. Patients visit hospitals first for treatment, then they go to specialty clinics. Clinics also often use the most technologically advanced products. These factors also contribute to the growth of the segment. The retail pharmacies/e-commerce segment is expected to show a significant growth over the forecast period as websites provide a wider range of products.

Regional Insights

North America was the market leader in 2017, and it is expected to continue its steady growth over the next few years. The market's growth is due to the high prevalence of skin-related disorders and burn injuries. The market growth is also supported by the availability and acceptance of advanced treatments such as lasers.

The U.S. government reimburses scar treatment for burn injuries. This is expected to have a positive effect on the local market. Europe saw a significant increase in the number and quality of plastic surgery units in 2017. This region is a highly lucrative market because of its favorable reimbursement policies.

Asia Pacific will see the fastest CAGR during the forecast period due to the availability of advanced products and the presence of many manufacturers in countries such as China. The market has seen a rise in demand for laser instruments, which are now available at lower prices in emerging markets. India, which has a high rate of burn injuries, has contributed greatly to the region's expansion.

Market Share insights for Hypertrophic and Keloid Scar Treatment

Smith & Nephew PLC, Enaltus, LLC, Merz, Inc., Lumenis, Sonoma Pharmaceuticals, Cynosure, Inc., Scar Heal, Inc., Molnlycke Health Care AB, Perrigo Company plc, NewMedical Technology, Inc., Suneva Medical, Inc., and Pacific World Corporation are some of the major market players.

To expand their businesses, major manufacturers have taken strategic initiatives such as product development and mergers and acquisitions. Merz North America, Inc., for example, announced in April 2017 the launch of Mederma Spezial, and Mederma Quick Dry Oil, which are both used to treat scarring.

Hypertrophic and Keloid Scar Treatment Market Report Scope

The Report Covers Certain Segments

This report predicts revenue growth and volume growth at the global, regional and country level. It also provides analysis of industry trends for each sub-segment from 2014 through 2025. Grand View Research has divided the global hypertrophic and keloid scar treatment market by scar type, product, end-use, region, and country.

• Scar Type Outlook (Revenue USD Million, 2014-HT0_2025)

  • Hypertrophic

  • Keloid

• Product Outlook (Revenue USD Million, 2014-2025)

  • Topical Products

    • Silicone Sheets

    • Creams

    • Gels

    • Other

  • Laser products

    • Pulse-dyed

    • CO ₂

    • Other

  • Injectable

  • Other

• End-Use Outlook (Revenue USD Million, 2014-2025)

  • Hospitals

  • Clinics

  • Retail Pharmacies/E-commerce

• Regional Outlook (Revenue USD Million, 2014-2025)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa

These are the most frequently asked questions about this report

b. Global hypertrophic and Keloid Scar Treatment Market Size was USD 5,765.1 Million in 2019. It is expected to grow to USD 6,321.0 Million in 2020.

b. Global hypertrophic and Keloid Scar Treatment Market is expected to grow at a compound annual rate of 9.9% between 2018-2025, to reach USD 10,163.0 Million by 2025.

b. With a 35.2% share in 2019, North America was the dominant market for hypertrophic and Keloid scar treatment. This can be attributed to the high incidence of burn injuries, skin disorders, and trauma.

b. Smith & Nephew PLC, Enaltus, LLC, Merz, Inc., Lumenis, Sonoma Pharmaceuticals, Cynosure, Inc., Scar Heal, Inc., Molnlycke Health Care AB, Perrigo Company plc, NewMedical Technology, Inc., Suneva Medical, Inc., and Pacific World Corporation are some of the key players in the hypertrophic scar treatment market.

b. The market growth is being driven by a rise in demand for esthetics and the increase in burn cases and technologically advanced products.

Up Market Research published a new report titled “Hypertrophic and Keloid Scar Treatment Market research report which is segmented by Product (Topical, Injectable, Laser), by End Use (E-commerce, Clinics), by Scar Type (Keloid, Hypertrophic), By Players/Companies Inc; and Pacific World Corporation, Inc; Scar Heal, Inc; Suneva Medical, LLC; Merz, Inc; Lumenis; Sonoma Pharmaceuticals; Cynosure, Inc; M¶lnlycke Health Care AB; Perrigo Company plc; NewMedical Technology, Smith & Nephew PLC; Enaltus”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Hypertrophic and Keloid Scar Treatment Market Report Segments:

The market is segmented by Product (Topical, Injectable, Laser), by End Use (E-commerce, Clinics), by Scar Type (Keloid, Hypertrophic).

Hypertrophic and Keloid Scar Treatment Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Hypertrophic and Keloid Scar Treatment Market

Overview of the regional outlook of the Hypertrophic and Keloid Scar Treatment Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Hypertrophic and Keloid Scar Treatment Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Hypertrophic and Keloid Scar Treatment Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.

                1. Topical

                2. Injectable

                3. Laser

                1. E-commerce

                2. Clinics

                1. Keloid

                2. Hypertrophic

9. Market scenario by region, sub-region, and country.
10. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
11. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
12. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Hypertrophic and Keloid Scar Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Hypertrophic and Keloid Scar Treatment Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.